Therapeutic effects of walnut oil on the animal model of multiple sclerosis

References

• Leray E, Moreau T, Fromont A, Edan G. Epidemiology of multiple sclerosis. Rev Neurol-France 2016;172(1):3–13.
   PubMed Web of Science ®Google Scholar
• Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care 2013;19(2 Suppl):S15–20.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi m, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(2):292–302.
   PubMed Web of Science ®Google Scholar
• Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. New Engl J Med 2000;343(20):1430–8.
   PubMed Web of Science ®Google Scholar
• Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 2005;11(4):459–63.
   PubMed Web of Science ®Google Scholar
• Lovett-Racke AE, Yang Y, Racke MK. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochimica et Biophysica Acta 2011;1812(2):246–51.
   PubMed Web of Science ®Google Scholar
• Kanhere A, Hertweck A, Bhatia U, Gökmen MR, Perucha E, Jackson I, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun 2012;3:1268.
   PubMed Web of Science ®Google Scholar
• Singh B, Schwartz JA, Sandrock C, Bellemore SM, Nikoopour E. Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells. Indian J Med Res 2013;138(5):591.
   PubMedGoogle Scholar
• Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, et al. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+ CD4+ regulatory T cells. Int Immunol 2004;16(2):249–56.
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Yu C-R, Sun L, Wang R. Interleukin 35: critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev 2015;26(5):587–93.
   PubMed Web of Science ®Google Scholar
• Heimendinger J, Van Duyn MA, Chapelsky D, Foerster S, Stables G. The national 5 A Day for Better Health Program: a large-scale nutrition intervention. J Public Health Man 1996;2(2):27–35.
   PubMedGoogle Scholar
• Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27(5):845–52.
   PubMed Web of Science ®Google Scholar
• Choi Y, Abdelmegeed MA, Akbar M, Song B-J. Dietary walnut reduces hepatic triglyceride content in high-fat-fed mice via modulation of hepatic fatty acid metabolism and adipose tissue inflammation. J Nutr Biochem 2016;30:116–25.
   PubMedGoogle Scholar
• Beer R, Kaiser F, Schmidt K, Ammann B, Carraro G, Grisa E, et al. Vegetation history of the walnut forests in Kyrgyzstan (Central Asia): natural or anthropogenic origin? Quaternary Sci Rev 2008;27(5):621–32.
   Web of Science ®Google Scholar
• Abdallah IB, Tlili N, Martinez-Force E, Rubio AGP, Perez-Camino MC, Albouchi A, et al. Content of carotenoids, tocopherols, sterols, triterpenic and aliphatic alcohols, and volatile compounds in six walnuts (Juglans regia L.) varieties. Food Chemistry 2015;173:972–8.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY. Nutraceuticals of anti-inflammatory activity as complementary therapy for rheumatoid arthritis. Toxicol Ind Health 2014;30(8):738–49.
   PubMed Web of Science ®Google Scholar
• Poulose SM, Bielinski DF, Shukitt-Hale B. Walnut diet reduces accumulation of polyubiquitinated proteins and inflammation in the brain of aged rats. J Nutr Biochem 2013;24(5):912–9.
   PubMed Web of Science ®Google Scholar
• McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol 1992;38(3):229–40.
   PubMed Web of Science ®Google Scholar
• Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ. A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. J Neurosci Meth 2007;163(2):245–54.
   PubMed Web of Science ®Google Scholar
• Mosayebi G, Ghazavi A, Salehi H, Payani MA, Khazae MR. Effect of sesame oil on the inhibition of experimental autoimmune encephalomyelitis in C57BL/6 mice. Pakistan J Biol Sci 2007;10(11):1790–6.
   PubMedGoogle Scholar
• Kuerten S, Kostova-Bales DA, Frenzel LP, Tigno JT, Tary-Lehmann M, Angelov DN, et al. MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J Neuroimmunol 2007;189(1–2):31–40.
   PubMed Web of Science ®Google Scholar
• Eugster HP, Frei K, Winkler F, Koedel U, Pfister W, Lassmann H, et al. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur J Immunol 2001;31(8):2302–12.
   PubMed Web of Science ®Google Scholar
• Hofstetter HH, Karulin AY, Forsthuber TG, Ott PA, Tary-Lehmann M, Lehmann PV. The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice. J Neuroimmunol 2005;170(1–2):105–14.
   PubMed Web of Science ®Google Scholar
• Ghazavi A, Mosayebi G. The mechanism of sesame oil in ameliorating experimental autoimmune encephalomyelitis in C57BL/6 mice. Phytotherapy Res 2012;26(1):34–8.
   PubMed Web of Science ®Google Scholar
• Molaee N, Mosayebi G, Pishdadian A, Ejtehadifar M, Ganji A. Evaluating the proliferation of human peripheral blood mononuclear cells using MTT assay. Int J Basic Sci Med 2017;2(1):25–8.
   Google Scholar
• Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, et al. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180(5):1961–6.
   PubMed Web of Science ®Google Scholar
• Greer JM, Kuchroo VK, Sobel RA, Lees MB. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178–191) for SJL mice. J Immunol 1992;149(3):783–8.
   PubMed Web of Science ®Google Scholar
• Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78(4):318–23.
   PubMed Web of Science ®Google Scholar
• Skurkovich B, Skurkovich S. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases. Curr Opin mol Ther 2003;5(1):52–7.
   PubMedGoogle Scholar
• Furlan R, Bergami A, Lang R, Brambilla E, Franciotta D, Martinelli V, et al. Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4. J Neuroimmunol 2000;111(1–2):86–92.
   PubMed Web of Science ®Google Scholar
• Mirshafiey A, Aghily B, Namaki S, Razavi A, Ghazavi A, Ekhtiari P, et al. Therapeutic approach by Aloe vera in experimental model of multiple sclerosis. Immunopharm Immunot 2010;32(3):410–5.
   PubMed Web of Science ®Google Scholar
• Miller A, al-Sabbagh A, Santos LM, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993;151(12):7307–15.
   PubMed Web of Science ®Google Scholar
• Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265(5176):1237–40.
   PubMed Web of Science ®Google Scholar
• Gor DO, Rose NR, Greenspan NS TH1-TH2: a procrustean paradigm. Natur Immunol 2003;4(6):503–5.
   PubMed Web of Science ®Google Scholar
• Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177(1):566–73
   PubMed Web of Science ®Google Scholar
• Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, et al. Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis. Brain 2008;131(Pt 7):1736–48.
   PubMedGoogle Scholar
• Eltayeb S, Berg AL, Lassmann H, Wallstrom E, Nilsson M, Olsson T, et al. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflamm 2007;4:14.
   PubMed Web of Science ®Google Scholar
• Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 2001;166(2):1314–9.
   PubMed Web of Science ®Google Scholar
• Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007;259(1–2):79–84.
   PubMed Web of Science ®Google Scholar
• Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis LA, Moutsatsou P. Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 2008;99(4):715–22.
   PubMed Web of Science ®Google Scholar
• Islam KN, Devaraj S, Jialal I. α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 1998;98(21):2255–61.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Lorenz M, Grimbo N, Steinle F, Meiners S, Bartsch C, et al. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Bioph Res Commun 2004;316(3):659–65.
   PubMed Web of Science ®Google Scholar
• Zapolska-Downar D, Zapolski-Downar A, Markiewski M, Ciechanowicz A, Kaczmarczyk M, Naruszewicz M. Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Commun 2000;274(3):609–15.
   PubMed Web of Science ®Google Scholar
• Wu D, Koga T, Martin KR, Meydani M. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999;147(2):297–307.
   PubMed Web of Science ®Google Scholar
• Anderson KJ, Teuber SS, Gobeille A, Cremin P, Waterhouse AL, Steinberg FM. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 2001;131(11):2837–42.
   PubMed Web of Science ®Google Scholar
• Yu YM, Wang ZH, Liu CH, Chen CS. Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells. Br J Nutr 2007;97(4):692–8.
   PubMed Web of Science ®Google Scholar
• Murase T, Kume N, Hase T, Shibuya Y, Nishizawa Y, Tokimitsu I, et al. Gallates inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of leukocyte adhesion molecules in vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999;19(6):1412–20.
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Hibasami H, Katsuzaki H, Imai K, Komiya T. Sesamolin from sesame seed inhibits proliferation by inducing apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2001;7(4):369–71.
   PubMed Web of Science ®Google Scholar